№1(7) 2024

DOI 10.37219/2528-8253-2024-1-22

Ostrovska DA

REMODELING OF NASAL MUCOSA DEPENDING ON THE PHENOTYPE OF CHRONIC RHINOSINUSITIS AND ENDOPROTEASE EXPRESSION

Ostrovska Daria A.
Bogomolets National Medical University, Kyiv, Ukraine
Postgraduate student of the Department of Otorhinolaryngology
E-mail: dr.ostrovskaya.d@gmail.com
ORCID: https://orcid.org/0009-0002-5983-6323

REMODELING OF NASAL MUCOSA DEPENDING ON THE PHENOTYPE OF CHRONIC RHINOSINUSITIS AND ENDOPROTEASE EXPRESSION

Ostrovska DA

Bogomolets National Medical University

Email: dr.ostrovskaya.d@gmail.com

Abstract

Background: As of today, chronic rhinosinusitis (CRS) characterized by inflammatory processes and tissue remodeling of the mucosal lining is classified into two phenotypes: chronic rhinosinusitis with nasal polyps (CRSwNP) and chronic rhinosinusitis without nasal polyps (CRSsNP). Matrix metalloproteinases (MMPs) constitute a family of zinc-dependent endopeptidases that play a crucial role in degrading basement membranes and extracellular matrix. MMP-7 and MMP-9 may play significant roles in CRS development.

Objective: To determine the level of zinc-dependent endopeptidases in the tissues of patients with CRSwNP and CRSsNP.

Materials and Methods: The study included 54 patients meeting the inclusion criteria, among them 12 patients in the control group, and 21 patients each in subgroup A (CRSwNP) and subgroup B (CRSsNP) of the main group. Patients underwent SNOT-22 questionnaire, endoscopic evaluation using the Lund-Kennedy scale, CT scans graded by the Lund-Mackay scale, and levels of MMP-9 and MMP-7 enzymes were determined in surgically removed fragments of pathological tissues.

Results: It was found that CRSwNP is more commonly associated with olfactory dysfunction. However, obstruction of the olfactory cleft by polypoid elements, according to CT scans, was observed in only 19.04% of cases (4 out of 21 patients). The level of MMP-7 for the control group was 8.17±5.15 μg/ml, for subgroup A it was 23.67±11.89 μg/ml, and for subgroup B it was 17.93±9.88 μg/ml. Student’s t-test revealed no significant difference between subgroups A and B of the main group, p>0.05 (T-statistic: 1.7; p-value: 0.09). However, when compared individually with the control group, a statistical difference was observed in each case, p<0.05. In contrast to MMP-7 data, statistically significant differences were observed when comparing the MMP-9 levels of each group using the t-test, p<0.05. The distribution of mean MMP-9 levels for the groups was as follows: control group – 17.49±8.81 μg/ml, subgroup A – 36.04±16.03 μg/ml, and subgroup B – 26.06±11.04 μg/ml.

Conclusions: MMP-9 and MMP-7 are key enzymes involved in the formation of polypoid tissue or pseudocysts in different phenotypes of CRS and influence the severity of the disease’s clinical course. Therefore, these endopeptidases could potentially serve as biomarkers for CRS activity and as targets for new therapeutic agents that could inhibit them.

Keywords: chronic rhinosinusitis, endoproteases, MMP-9, MMP-7, nasal cavity, nasal mucosa, nasal polyps, nasal cavity pseudocysts.

References

  1. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. Executive summary of EPOS 2020 including integrated care pathways. Rhinology. 2020 Apr 1;58(2):82-111. doi: 10. 4193/Rhin20.601.
  2. Bousquet J, Bachert C, Canonica GW, Mullol J, Van Cauwenberge P, Jensen CB, et al. Efficacy of desloratadine in persistent allergic rhinitis – a GA2LEN study. Int Arch Allergy Immunol. 2010;153(4):395-402. doi: 10.1159/000316351.
  3. Bachert C, Gevaert P, Holtappels G, Cuvelier C, van Cauwenberge P. Nasal polyposis: from cytokines to growth. Am J Rhinol. 2000;14(5):279-90. doi: 10.2500/105065800781329573.
  4. Van Bruaene N, Derycke L, Perez-Novo CA, Gevaert P, Holtappels G, De Ruyck N et al. TGF-beta signaling and collagen deposition in chronic rhinosinusitis. J Allergy Clin Immunol. 2009 Aug; 124(2):253-9, 259.e1-2. doi: 10.1016/j.jaci.2009. 013.
  5. Watelet JB, Bachert C, Claeys C, Van Cauwenberge P. Matrix metalloproteinases MMP‐7, MMP‐9 and their tissue inhibitor TIMP‐1: expression in chronic sinusitis vs nasal polyposis. Allergy. 2004 Jan;59(1):54-60. doi: 10.1046/j.1398-9995.2003.00364.x.
  6. Lechapt-Zalcman E, Coste A, d’Ortho MP, Frisdal E, Harf A, Lafuma C, et al. Increased expression of matrix metalloproteinase-9 in nasal polyps. J Pathol. 2001 Feb;193(2):233-41. doi: 10.1002/ 1096-9896(2000)9999:9999<::AID-PATH771>3.0.CO;2-W.
  7. Belleguic C, Corbel M, Germain N, Lena H, Boichot E, Delaval PH, Lagente Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy. 2002 Feb;32(2):217-23. doi: 10.1046/j.1365-2222.2002.01219.x.
  8. de Borja Callejas F, Picado C, Martínez-Antón A, Alobid I, Pujols L, Valero A, et al. Differential Expression of Remodeling Markers by Tissue Structure in Nasal Polyposis. Am J Rhinol Allergy. 2013;27(3):e69-74. doi: 10.2500/ajra.2013.27.3908.
  9. Guerra G, Testa D, Salzano FA, Tafuri D, Hay E, Schettino Bs A, et al. Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Chronic Rhinosinusitis With Nasal Polyps: Etiopathogenesis and Recurrence. Ear Nose Throat J. 2021 Sep;100(5_suppl):597S-605S. doi: 10.1177/
  10. Hamilos D. Chronic rhinosinusitis: epidemiology and medical management. J Allergy Clin Immunol. 2011 Oct;128(4):693-707; quiz 708-9. doi: 10.1016/j.jaci.2011.08.004.
  11. Deconde A, Soler Z. Chronic Rhinosinusitis: Epidemiology and Burden of Disease. Am J Rhinol Allergy. 2016 Mar-Apr;30(2):134-9. doi: 10.2500/ 2016.30.4297.
  12. Castagnoli R, Licari A, Brambilla I, Tosca M, Ciprandi G, Marseglia G. An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma. Expert Rev Respir Med. 2020 Dec;14(12):1197-1205. doi: 10.1080/ 2020.1812388.Order of the Ministry of Health of Ukraine from 13.10.2023 № 1793 “On approval of the Unified clinical protocol of primary and specialised medical care “Acute rhinosinusitis”, Unified clinical protocol of primary and specialised medical care “Chronic rhinosinusitis”. [In Ukrainian].